Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Selection and structural characterization of anti-TREM2 scFvs that reduce levels of shed ectodomain.

Szykowska A. et al, (2021), Structure (London, England : 1993), 29, 1241 - 1252.e5

A novel high-content imaging-based technique for measuring binding of Dickkopf-1 to low-density lipoprotein receptor-related protein 6

Priestley RS. et al, (2019), Journal of Pharmacological and Toxicological Methods, 95, 47 - 55

Tackling gaps in developing life‐changing treatments for dementia

Mauricio R. et al, (2019), Alzheimer's & Dementia: Translational Research & Clinical Interventions, 5, 241 - 253

Small vessels, dementia and chronic diseases – molecular mechanisms and pathophysiology

Horsburgh K. et al, (2018), Clinical Science, 132, 851 - 868

Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease

Broom L. et al, (2011), Free Radical Biology and Medicine, 50, 633 - 640

A Key Role for gp130 Expressed on Peripheral Sensory Nerves in Pathological Pain

Andratsch M. et al, (2009), Journal of Neuroscience, 29, 13473 - 13483

The effects of the TRPV1 receptor antagonist SB-705498 on trigeminovascular sensitisation and neurotransmission

Lambert GA. et al, (2009), Naunyn-Schmiedeberg's Archives of Pharmacology, 380, 311 - 325

Autoradiographical imaging of PPARγ agonist effects on PBR/TSPO binding in TASTPM mice

Roberts JC. et al, (2009), Experimental Neurology, 216, 459 - 470

Perspectives of Alzheimer's disease treatments

Davis JB. et al, (2008), 273 - 290

Load More